Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PRL-3: a phosphatase for metastasis?

Jason A Sager1, Silvia Benvenuti, Alberto Bardelli

  • 1The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University Medical Institutions, Baltimore, Maryland, USA.

Cancer Biology & Therapy
|October 7, 2004
PubMed
Summary

The PRL-3 phosphatase is a new focus in cancer research, potentially useful for metastatic tumors. Its catalytic activity is essential for metastasis in mouse models, suggesting it as a future therapeutic target.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neural cues differentially modulate colorectal cancer cell behavior depending on patients' genomic background.

iScience·2026
Same author

The Rising Burden of Early-Onset Cancer: Challenges and Opportunities.

Cancer discovery·2026
Same author

WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.

EMBO molecular medicine·2026
Same author

Mismatch Repair-Proficient Colorectal Cancer can evade Immune Surveillance Through an Intrinsic Suppressive Program.

Cancer discovery·2026
Same author

Pharmacological inhibition of PMS2 induces MMR deficiency and response to immune checkpoint blockade.

Cancer discovery·2026
Same author

Mapping intratumor heterogeneity across layers for advancing immunotherapy.

Cell·2026

Area of Science:

  • Molecular Biology
  • Oncology
  • Cancer Metastasis Research

Background:

  • The protein tyrosine phosphatase PRL-3 is emerging as a significant factor in cancer progression.
  • PRL-3 is being investigated as a prognostic marker and a potential therapeutic target for metastatic cancers.

Discussion:

  • Guo and colleagues demonstrate that the enzymatic activity of PRL-3 is crucial for the development of experimental metastasis in mice.
  • This finding reinforces the role of PRL-3 in the metastatic cascade.
  • Further research is needed to validate PRL-3 as a clinical diagnostic or therapeutic agent.

Key Insights:

  • The catalytic function of PRL-3 is indispensable for metastasis formation.
  • PRL-3's role in experimental metastasis highlights its potential as a drug target.

Related Experiment Videos

Outlook:

  • Future studies should focus on elucidating PRL-3's precise mechanisms in metastasis.
  • Translating these findings into clinical applications for human cancer diagnostics and therapeutics requires further investigation.
  • PRL-3 represents a promising target for anti-metastasis therapies.